milken, carls mike icahn, lloyd blankfein.d to loads of people i was friends with and i said, what do you think? half of them said, of course you should do that. this is a way to monetize your equity, a way to grow, an incentive for compensation you can add to the list to get better people. the other half said, are you out of your mind? why do you want to be in the regulatory fishbowl with the focus on you? so that wasn't very helpful. what i ultimately decided with my partners was that if we were going to just stay in private equity, probably it wasn't the right thing to do. on the other hand, if we wanted to build a global alternative asset antigen company in terms of credit, real assets, insurance, private equity, it was probably the right thing to do. regrets? absolutely. i think the public market does not understand creatures like us very well. they don't know how to value. incredibly, of us, i would say rare and valuable creatures. , youcompanies out there can say we are very value-oriented on one hand in terms of risk r